Findings suggest that certain medications for type 2 diabetes reduce risk of dementia

A large McGill University study has found that two classes of medications commonly prescribed for type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.

Continue Reading

News Source: medicalxpress.com